Your session is about to expire
Rosuvastatin vs Atorvastatin
Introduction
For patients with high cholesterol levels or other types of cardiovascular diseases, certain drugs that inhibit the production of cholesterol in the liver can help manage these conditions. Rosuvastatin and Atorvastatin are two such medications often prescribed to treat hypercholesterolemia. They each impact different biochemical pathways within hepatocytes but both have a significant effect on lowering LDL (low-density lipoprotein) cholesterol levels in patients suffering from high cholesterol.
Rosuvastatin, sold under the brand name Crestor among others, is considered one of the most potent statins available in terms of its ability to reduce LDL-cholesterol concentrations. On the other hand, Atorvastatin, popularly known as Lipitor, is another highly effective drug for managing high cholesterol and has been extensively studied for its benefits beyond just lipid-lowering effects including stabilizing plaques in arteries and reducing inflammation.
Rosuvastatin vs Atorvastatin Side By Side
| Attribute | Crestor | Lipitor |
|---|---|---|
| Brand Name | Crestor | Lipitor |
| Contraindications | Should not be taken with drugs like cyclosporine, gemfibrozil, or antiviral medicines used in the treatment of HIV/AIDS. May increase blood sugar levels. | Should not be taken with drugs like cyclosporine, gemfibrozil, or antiviral medicines used in the treatment of HIV/AIDS. May increase blood sugar levels. |
| Cost | Brand: ~$200 for 30 tablets of 10 mg, Generic: starts from about $0.50 per day | Brand: ~$150 for 30 tablets of 20 mg, Generic: starts as low as $0.15 per day |
| Generic Name | Rosuvastatin | Atorvastatin |
| Most Serious Side Effect | Rhabdomyolysis | Liver problems, kidney issues |
| Severe Drug Interactions | Cyclosporine, gemfibrozil, antiviral medicines for HIV/AIDS | Cyclosporine, gemfibrozil, antiviral medicines for HIV/AIDS |
| Typical Dose | 5–40 mg/day, with 10-20 mg/day being typical for most adults | 10–80 mg/day, starting dose usually 10-20 mg/day |
What is Rosuvastatin?
Rosuvastatin (known by the brand name Crestor) and Atorvastatin (the generic name for Lipitor) are both part of a class of drugs known as statins, which have revolutionized the management of high cholesterol levels. Both these medications work by inhibiting an enzyme necessary for your body to produce cholesterol. Rosuvastatin was approved later than Atorvastatin, receiving FDA approval in 2003 compared to Atrovastin's 1996 approval.
These two drugs are prescribed primarily to lower LDL (low-density lipoprotein), often referred to as 'bad' cholesterol, and triglycerides in patients with hyperlipidemia or mixed dyslipidemia. Additionally, they raise HDL ('good') cholesterol levels.
While both medications are similar in their effects on lipid profiles, studies suggest that Rosuvastatin might be more potent at equivalent doses when compared to Atorvastatin. This means it may result in greater reduction of LDL-cholesterol at similar doses. However, the choice between these two medicines will also depend on a person's individual health profile and potential side effects.
What conditions is Rosuvastatin approved to treat?
Rosuvastatin and Atorvastatin are both approved for the treatment of various conditions related to heart disease:
- Primary hyperlipidemia, also known as high cholesterol
- Mixed dyslipidemia, a condition characterized by abnormal levels of lipids in the blood
- Hypertriglyceridemia, or high triglyceride levels In addition to these conditions, they can also be used to reduce the risk of cardiovascular events in patients with established cardiovascular disease or those at high risk.
How does Rosuvastatin help with these illnesses?
Rosuvastatin works to manage high cholesterol by inhibiting an enzyme called HMG-CoA reductase in the liver, this is a key component in the production of cholesterol. By blocking it from being produced, levels can be maintained lower for longer periods of time. Cholesterol is a type of fat that circulates in your blood and plays essential roles such as assisting in building cell membranes and producing certain hormones. However, when individuals have relatively higher levels of low-density lipoprotein (LDL), known as 'bad' cholesterol, they are at risk for developing cardiovascular diseases like heart attacks or strokes. Therefore, by decreasing LDL cholesterol with Rosuvastatin use, patients can limit the negative effects associated with high cholesterol and help manage their condition more effectively.
What is Atorvastatin?
Atorvastatin, often known by its brand name Lipitor, is a statin medication designed to lower lipid levels and thus reduce the risk of cardiovascular disease. It functions as an inhibitor of HMG-CoA reductase, meaning it suppresses the enzyme responsible for producing cholesterol in your liver. Atorvastatin was first approved by the FDA in 1996 and has since become one of the top-selling pharmaceutical drugs worldwide.
Because Atorvastatin does not directly affect serotonin or dopamine levels within its mechanism of action, it doesn't cause sedation nor impact weight or sexual function—common side effects associated with SSRIs like Prozac. Instead, potential side effects are more commonly related to muscle and liver health. Also worth noting is that Atorvastatin can provide significant benefits for patients at high risk of heart attack or stroke due to elevated cholesterol levels—a benefit distinct from those offered by typical antidepressants such as Prozac.
What conditions is Atorvastatin approved to treat?
Atorvastatin is a widely used statin that has been approved by the FDA for the treatment of:
- High cholesterol and triglycerides
- To slow the progression of atherosclerosis, a condition where fatty deposits build up in arteries
- In conjunction with lifestyle changes (diet, exercise), to reduce the risk of heart attack and stroke in patients with multiple cardiovascular risk factors
How does Atorvastatin help with these illnesses?
Atorvastatin is a statin medication that plays a role in many processes within the body, primarily by inhibiting the enzyme HMG-CoA reductase. This action slows down cholesterol production in the liver, thus effectively lowering LDL ("bad") cholesterol levels and increasing HDL ("good") cholesterol. It's been suggested that high levels of LDL cholesterol can lead to cardiovascular disease. Atorvastatin works by boosting the body's ability to decrease these harmful levels, thereby reducing some risks associated with heart disease and stroke. Its effects on triglycerides further contribute to its cardio-protective benefits. While it functions similarly to other statins such as rosuvastatin, atorvastatin may be prescribed when patients are not responding adequately to other treatments or have particular needs based on their medical history and current health status.
How effective are both Rosuvastatin and Atorvastatin?
Both rosuvastatin (Crestor) and atorvastatin (Lipitor) are statin medications that have been widely prescribed for managing high cholesterol levels, having received FDA approval in 2003 and 1996 respectively. Statins work by inhibiting the enzyme HMG-CoA reductase, which is a key component of cholesterol synthesis in the liver. As such, both drugs may be recommended for patients with hypercholesterolemia or those at risk for cardiovascular disease.
Comparative studies between these two statins show that they present similar safety profiles while exhibiting efficacy in reducing LDL ("bad") cholesterol levels. A 2010 direct comparison study showed that rosuvastatin might reduce LDL-cholesterol to a greater extent than atorvastatin when given at maximum doses. However, this difference was not observed when comparing moderate doses of each medication.
A meta-analysis from 2015 indicated that both medications significantly reduced total cholesterol and triglyceride levels while increasing HDL ("good") cholesterol slightly. The incidence of adverse events did not statistically differ between groups treated with either drug.
Despite being younger than its counterpart, rosuvastatin has quickly become one of the most commonly prescribed statins worldwide due to its potency even at low doses. On the other hand, despite being older and less potent milligram-for-milligram compared to rosuvastatin, atorvastatin is often preferred because it has a longer half-life allowing once-daily dosing and because it comes in generic form making it more cost-effective.
In terms of side effects profile; muscle-related symptoms like myalgia were reported more frequently by patients taking higher dose strength of any statin including Rosuvstatin & Atorvostatim but no significant differences were found on renal or hepatic function across both treatments offering reassurance about their long-term safety if used appropriately under medical supervision.
Related trials for rosuvastatin and atorvastatin
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Rosuvastatin typically prescribed?
Oral dosages of Rosuvastatin range from 5–40 mg/day, but studies have indicated that 10-20 mg/day is typically sufficient for managing high cholesterol in most adults. Children aged 8 to 17 may be started on a dose of 5-10 mg/day. For both groups, dosage can be reviewed and possibly increased after several weeks if the response is not adequate. It's important to note that the maximum dosage should not exceed 40mg/day under any circumstance.
On the other hand, Atorvastatin has an oral dosing range between 10–80 mg/day with typical starting doses for high cholesterol management being around at least 10-20mg daily in adults and adolescents over ten years old. Like Rosuvastatin, this drug's dosage can also be gradually increased every few weeks based on patient response; its maximum recommended dose per day is also similar at no more than80mg.
Keep in mind these are general guidelines; always follow your healthcare provider's advice when it comes to medication dosages.
At what dose is Atorvastatin typically prescribed?
Atorvastatin therapy typically begins with a dosage of 10-20 mg/day, depending on the patient's LDL levels and cardiovascular risk. Depending on the response to treatment and tolerance to the medication, your doctor might increase this dose every two to four weeks up to a maximum daily dose of 80 mg. This can be taken in one single dose at any time during the day, but it is generally advised that you take it at roughly the same time each day for ease of remembering. If after several weeks there are no significant reductions in cholesterol levels or if side effects occur, your healthcare provider may choose to adjust your Atorvastatin dosage accordingly.
What are the most common side effects for Rosuvastatin?
Common side effects of Rosuvastatin and Atorvastatin vary but can include:
- Muscle pain or weakness, known as myopathy
- Headache
- Nausea
- Abdominal discomfort or pain
- Constipation, diarrhea
- Dizziness
- Insomnia (trouble sleeping)
- Joint pain (arthralgia)
- Increased blood sugar levels
- Rash Notably, these medications may also cause a decrease in liver function and rare but serious side effects such as rhabdomyolysis (breakdown of muscle tissue). If you experience any severe symptoms while on either rosuvastatin or atorvastatin, seek immediate medical attention.
Are there any potential serious side effects for Rosuvastatin?
While both Rosuvastatin and Atorvastatin are generally considered safe, they can cause side effects in rare circumstances:
- Signs of a severe allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue or throat.
- Muscle weakness or tenderness. This could be a sign of serious muscle problems that can lead to kidney damage.
- Unusual fatigue or weakness
- Dark urine or yellowing of the skin or eyes (jaundice)
- Severe stomach pain
- Persistent nausea/vomiting
- Chest pain, especially if it spreads to your jaw or shoulder and you feel anxious or light-headed.
It's worth noting that these are not common side effects for either drug. However, it's important to immediately seek medical help if you experience any of them after starting treatment with these medications.
What are the most common side effects for Atorvastatin?
Atorvastatin, similar to Rosuvastatin, can also cause several side effects. These may include:
- Mild nausea or stomach pain
- Constipation and difficulty with digestion
- A headache or dizziness
- Sleep problems (insomnia)
- Feeling weak or tired
- A mild skin rash However, it's important to note that severe side effects are rare but should you experience symptoms such as confusion, unusual fatigue or muscle weakness - especially if these occur alongside a fever and dark colored urine - this could indicate a serious condition that requires immediate medical attention. Always consult your healthcare provider for professional advice tailored to your specific circumstances.
Are there any potential serious side effects for Atorvastatin?
Atorvastatin, though generally safe and effective for lowering cholesterol levels, can in rare cases lead to severe side effects. Some potentially serious adverse reactions to be aware of include:
- Symptoms of an allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue or throat
- Liver problems which may manifest as loss of appetite, upper stomach pain, tiredness, dark urine or jaundice (yellowing of the skin or eyes)
- Kidney issues that might result in little to no urination
- Unexplained muscle weakness or tenderness coupled with fever
- Memory problems and confusion If you experience any one of these symptoms while taking atorvastatin it is advisable that you consult a healthcare provider immediately.
Contraindications for Rosuvastatin and Atorvastatin?
Both Rosuvastatin and Atorvastatin, along with most other cholesterol-lowering medications, may cause muscle pain or weakness. If you notice these symptoms worsening, please seek immediate medical attention.
Neither Rosuvastatin nor Atorvastatin should be taken if you are taking drugs like cyclosporine, gemfibrozil or antiviral medicines used in the treatment of HIV/AIDS. Always tell your doctor which medications you are taking; these drugs can interact with Rosuvastatin and Atorvastatin leading to potentially dangerous health effects such as kidney disease.
Additionally, both statins might increase blood sugar levels thus increasing the risk of developing type 2 diabetes. Regular monitoring is advised for patients at an already higher risk for this condition.
How much do Rosuvastatin and Atorvastatin cost?
For the brand name versions of these drugs:
- The price of 30 tablets of Crestor (rosuvastatin 10 mg) averages around $200, which works out to approximately $6-$7/day depending on your dose.
- The price of 30 tablets of Lipitor (atorvastatin 20 mg) is about $150, working out to roughly $5/day.
Thus, if you are in a higher dosage range for rosuvastatin (i.e., 40 mg/day), then brand-name atorvastatin may be less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which drug suits you best.
Moving to their generic counterparts:
- Generic atorvastatin is available in packs from 30 up to even more than hundred pills, with costs starting as low as $0.15 per day if bought upfront and not exceeding about $1/day.
- Rosuvastatin comes similarly packaged and priced: it starts from about $0.50 per day going upwards till around just over a dollar ($1).
Again, prices can vary based on factors like location and insurance coverage but generics always offer substantial savings versus the branded versions.
Popularity of Rosuvastatin and Atorvastatin
Rosuvastatin, in generic form as well as brand names such as Crestor, was estimated to have been prescribed to about 21 million people in the US in 2020. Rosuvastatin accounted for just over 23% of statin prescriptions in the US. However, it appears to be one of the most potent “statins” used to lower cholesterol levels and reduce risk of cardiovascular disease. The use of rosuvastatin has been generally increasing since its introduction.
Atorvastatin, including brand versions such as Lipitor, was prescribed to nearly 94 million people in the USA in 2020. In the US, atorvastatin accounts for almost half of all statin prescriptions and is one of the most commonly prescribed drugs overall. The prevalence of atorvastatin has remained strong due to its efficacy and affordability with generic availability.
Conclusion
Both Rosuvastatin and Atorvastatin have a strong history of usage in patients with high cholesterol, backed by countless clinical studies indicating their efficacy compared to placebo treatments. Sometimes, these drugs may be used together under careful consideration by a physician as they can interact with one another. Because of their different potency levels and half-life, with Rosuvastatin being more potent and having a longer half-life than Atorvastatin, they are prescribed based on specific patient circumstances.
Atorvastatin is often the first-line treatment for high cholesterol due to its affordability while Rosuvastatin might be considered if patients do not respond well to initial statin therapy or need aggressive LDL lowering.
Both drugs are available in generic form which offers significant cost savings particularly for patients who pay out-of-pocket. Both medications may require an adjustment period meaning that full effects might not be noticeable immediately.
The side effect profile is similar between these two drugs; both are generally well-tolerated but common side effects include muscle pain, liver damage and increased blood sugar levels. For both medications, it's important that individuals monitor any changes in health closely when starting treatment especially symptoms like unexplained muscle pain or weakness as this could indicate severe side effects such as rhabdomyolysis which requires immediate medical attention.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Soliemanabad, S. K., Rasouli, K., Zakariaei, Z., Soleymani, M., & Aliabadi, P. K. (2022, March). Rhabdomyolysis due to warfarin and atorvastatin combination therapy in a patient with ischemic heart disease: (A drug interaction). Annals of Medicine & Surgery. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1016/j.amsu.2022.103384
- Voloshyna, D., Al Barznji, S., Shaik, T. A., Rizvi, A., Sachdev, R., Pritwani, P., … Ghaffari, M. A. Z. (2022, September 5). Atorvastatin as a Rare Primary Cause of Drug-Induced Angioedema: A Case Report. Cureus. Springer Science and Business Media LLC.http://doi.org/10.7759/cureus.28788
- Chang, J. T., Staffa, J. A., Parks, M., & Green, L. (2004, May 24). Rhabdomyolysis with HMG‐CoA reductase inhibitors and gemfibrozil combination therapy. Pharmacoepidemiology and Drug Safety. Wiley.http://doi.org/10.1002/pds.977
- Lopez, L. M. (2005, July). Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor. Journal of the American Pharmacists Association. Elsevier BV.http://doi.org/10.1331/1544345054475522
- Culhane, N. S., Lettieri, S. L., & Skae, J. R. (2005, July). Rosuvastatin for the Treatment of Hypercholesterolemia. Pharmacotherapy. Wiley.http://doi.org/10.1592/phco.2005.25.7.990
- Nicholls, S. J., Uno, K., & Kataoka, Y. (2011, November). Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk. Expert Review of Cardiovascular Therapy. Informa UK Limited.http://doi.org/10.1586/erc.11.145
- Yamagishi, S.-. ichi ., Matsui, T., & Nakamura, K. (2006, April 1). Atorvastatin and Diabetic Vascular Complications. Current Pharmaceutical Design. Bentham Science Publishers Ltd.http://doi.org/10.2174/138161206776389796
- McKenney, J. M., Jones, P. H., Adamczyk, M. A., Cain, V. A., Bryzinski, B. S., Blasetto, J. W., & for the STELLAR Study Group. (2003, January). Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. Current Medical Research and Opinion. Informa UK Limited.http://doi.org/10.1185/030079903125002405
- Braamskamp, M. J. A. M., Langslet, G., McCrindle, B. W., Cassiman, D., Francis, G. A., Gagné, C., … Kastelein, J. J. P. (2015, November). Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study. Journal of Clinical Lipidology. Elsevier BV.http://doi.org/10.1016/j.jacl.2015.07.011
- Lee, C. W., Baek, S.-H., Hong, T.-J., Choi, Y.-J., Kim, Y.-J., Ahn, T.-H., … Kim, H.-S. (2010, April). A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing the Percentage of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target with Atorvastatin Starting Doses of 10 mg, 20 mg and 40 mg. Cardiovascular Drugs and Therapy. Springer Science and Business Media LLC.http://doi.org/10.1007/s10557-010-6225-0
- Cournot, M., Cambou, J.-P., Quentzel, S., & Danchin, N. (2006, July). Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys. International Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/j.ijcard.2005.06.039
- Suthar, K. S. (2015). Acute Kidney Injury and Quadriparesis Due to Rosuvastatin Induced Rhabdomyolysis- A Case Report. Journal Of Clinical And Diagnostic Research. JCDR Research and Publications.http://doi.org/10.7860/jcdr/2015/12117.5909
- Mazza, F., Stefanutti, C., Di Giacomo, S., Vivenzio, A., Fraone, N., Mazzarella, B., & Bucci, A. (2008). Effects of Low-Dose Atorvastatin and Rosuvastatin on Plasma Lipid Profiles. American Journal of Cardiovascular Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00129784-200808040-00006
- Miller, P. S. J., Smith, D. G., & Jones, P. (2005, June). Cost Effectiveness of Rosuvastatin in Treating Patients to Low-Density Lipoprotein Cholesterol Goals Compared With Atorvastatin, Pravastatin, and Simvastatin (a US Analysis of the STELLAR Trial). The American Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/j.amjcard.2005.01.074
- Sen, S., & Nikalji, R. (2021). Rosuvastatin-induced rhabdomyolysis: A case report. Indian Journal of Nephrology. Scientific Scholar.http://doi.org/10.4103/ijn.ijn_388_19